By Brian C. Joondeph on AmericanThinker.com
A study published several months ago in the American Journal of Therapeutics concluded,
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
To my knowledge, these 18 studies have not been retracted, unlike previous studies critical of hydroxychloroquine which were ignominiously retracted by prestigious medical journals like The Lancet and the New England Journal of Medicine.
Yet the medical establishment refuses to even entertain the possibility of some benefit from ivermectin, castigating physicians who want to try it in their patients. 18 studies found benefit. Are they all wrong?